Although single or multiple daily subcutaneous injections of insulin with syringes are the mainstay of insulin delivery techniques for the treatment of diabetes mellitus, several other methods are now available. The present paper will review the main problems occurring with the classical subcutaneous insulin therapy and the possible solutions given by the use of new devices, including more particularly insulin jet injectors, pens, and portable pumps. This review has to be considered as an introduction to the presentations of this symposium devoted to implantable pumps, glucose sensors, and artificial pancreas, respectively
Introduction Patients with diabetes type 1 (DM1) struggle daily to achieve good glucose control. The...
Purpose of Review To update the medical community on the new and old technologies use for the contro...
Abstract The incidence of Diabetes Mellitus is on the rise worldwide, which exerts enormous health t...
Technological inventions are being used recently to enable the treatment of diabetes mellitus more e...
Insulin is a key player in the control of hyperglycemia for type 1 diabetes patients and selective i...
Technology for diabetes care has undergone major development during recent decades. These technologi...
Introduction: The morbidity of diabetes mellitus is increasing, and subcutaneous injection of exogen...
Abstract Type 1 diabetes is one of the most common endocrine problems in childhood and adolescence, ...
Continuous subcutaneous insulin, or the insulin pump, has gained popularity and sophistication as a ...
International audienceAutomated insulin delivery (AID) systems, so-called closed-loop systems or art...
Type 1 diabetes mellitus (T1DM) represents 5-10% of diabetes cases worldwide. The incidence of T1DM ...
Insulin replacement therapy is integral to the management of type 1 diabetes, which is characterised...
A major new approach to the improvements of metabolic control in insulin-dependent diabetic patients...
To the best of our knowledge, a good glycaemic control must be advised to avoid or delay the degener...
INTRODUCTION: Type 1 diabetes is characterised by destruction of pancreatic beta cells, leading to i...
Introduction Patients with diabetes type 1 (DM1) struggle daily to achieve good glucose control. The...
Purpose of Review To update the medical community on the new and old technologies use for the contro...
Abstract The incidence of Diabetes Mellitus is on the rise worldwide, which exerts enormous health t...
Technological inventions are being used recently to enable the treatment of diabetes mellitus more e...
Insulin is a key player in the control of hyperglycemia for type 1 diabetes patients and selective i...
Technology for diabetes care has undergone major development during recent decades. These technologi...
Introduction: The morbidity of diabetes mellitus is increasing, and subcutaneous injection of exogen...
Abstract Type 1 diabetes is one of the most common endocrine problems in childhood and adolescence, ...
Continuous subcutaneous insulin, or the insulin pump, has gained popularity and sophistication as a ...
International audienceAutomated insulin delivery (AID) systems, so-called closed-loop systems or art...
Type 1 diabetes mellitus (T1DM) represents 5-10% of diabetes cases worldwide. The incidence of T1DM ...
Insulin replacement therapy is integral to the management of type 1 diabetes, which is characterised...
A major new approach to the improvements of metabolic control in insulin-dependent diabetic patients...
To the best of our knowledge, a good glycaemic control must be advised to avoid or delay the degener...
INTRODUCTION: Type 1 diabetes is characterised by destruction of pancreatic beta cells, leading to i...
Introduction Patients with diabetes type 1 (DM1) struggle daily to achieve good glucose control. The...
Purpose of Review To update the medical community on the new and old technologies use for the contro...
Abstract The incidence of Diabetes Mellitus is on the rise worldwide, which exerts enormous health t...